Rallybio (RLYB) Other Working Capital Changes (2024 - 2026)
Rallybio (RLYB) posted Other Working Capital Changes of -$212000.0 for Q1 2026, little changed sequentially from -$212000.0 in Q4 2025, and little changed YoY from -$212000.0 in Q1 2025.
Rallybio (RLYB) Other Working Capital Changes (2024 - 2026) Analysis & Trends
Rallybio has reported Other Working Capital Changes for 3 years, with the latest figure at -$212000.0 in Q1 2026.
- Quarterly Other Working Capital Changes changed 0.0% year-over-year to -$212000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$848000.0 (down 200.0% YoY) and the FY2025 annual result came in at -$848000.0, down 180.0% from the prior year.
- Other Working Capital Changes was little changed at -$212000.0 in Q1 2026 per RLYB's latest filing, from -$212000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $2.6 million in Q3 2022 and troughed at -$6.2 million in Q4 2023.
- A 5-year average of -$100000.0 and a median of $340000.0 in 2023 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 29.33% in 2025, down 472.97% in 2025.
- Over 3 years, Other Working Capital Changes stood at -$37000.0 in 2024, then slumped by 472.97% to -$212000.0 in 2025, then changed by 0.0% to -$212000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$212000.0, -$212000.0, and -$212000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Rallybio | 94.61 Mn | 94.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -212,000.00 |
| Mar 31, 2026 | -212,000.00 |
| Mar 31, 2026 | -212,000.00 |
| Dec 31, 2025 | -212,000.00 |
| Dec 31, 2025 | -212,000.00 |
| Dec 31, 2025 | -212,000.00 |
| Sep 30, 2025 | -212,000.00 |
| Sep 30, 2025 | -212,000.00 |
| Sep 30, 2025 | -212,000.00 |
| Jun 30, 2025 | -212,000.00 |
| Jun 30, 2025 | -212,000.00 |
| Jun 30, 2025 | -212,000.00 |
| Mar 31, 2025 | -212,000.00 |
| Mar 31, 2025 | -212,000.00 |
| Mar 31, 2025 | -212,000.00 |
| Dec 31, 2024 | -37,000.00 |
| Dec 31, 2024 | -37,000.00 |
| Dec 31, 2024 | -37,000.00 |
| Sep 30, 2024 | -300,000.00 |
| Sep 30, 2024 | -300,000.00 |